| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.26 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 4e-05 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.18 | 4e-05 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 7e-05 |